omniamol.com
Highlights
http://www.omniamol.com/highlights
AaRS 2015 10th International Symposium on Aminoacyl-tRNA Synthetases. Thursday, 15 October 2015 00:00. Http:/ www.aars2015.cat/en/. Omnia involved in chemical patent application. Monday, 13 April 2015 00:00. Omnia Molecular S.L., a founding partner of the NABARSI 7FP international project consortium, is playing a key role in screening small organic molecules against aminoacyl-tRNA synthetases from the drug-resistant pathogenic bacterial species;. Friday, 30 January 2015 00:00. Is an FP7-funded consortium...
omniamol.com
Mycosis | Projects
http://www.omniamol.com/projects/mycosis
Infections caused by pathogenic fungi (including Aspergillus fumigatus and Candida albicans) pose an important threat especially to immunocompromised patients. The aim of the consortium is to find new lead compounds. That inhibit the activity. Of arginyl-tRNA synthetase (RRS). Omnia's platform has already driven the discovery of several high quality hits. By lowering the attrition rate associated with screening processes. INNOVATIVE TECHNOLOGIES IN BIOLOGICAL SYSTEMS, S.L.
sictec-project.eu
Single Cell Technologies for SMEs: Partners
http://www.sictec-project.eu/partners
Single Cell Technologies for SMEs. 32;» Partners. The SICTEC project is conducted by a strong project team consisting of the following SMEs and research institutes:. Contact: Wolfgang Streule ( wolfgang.streule@ remove-this. Website: www.biofluidix.com. BiosparQ B.V. (The Netherlands). Contact: Gerold de Valk ( devalk@ remove-this. Website: www.biosparq.nl. Contact: Guillaume LHERMITE ( glhermite@ remove-this. Website: www.primadiag.com. Contact: Clarisa Salado ( csalado@ remove-this. Contact: André Gro...
ontarget-ddss.co.jp
Innoprot社|オンターゲット株式会社
http://www.ontarget-ddss.co.jp/supplier-innoprot.html
社では、Stable cell line、Primary cellを用いた細胞ベースのアッセイサービスを中心に提供しています。 独自のProprietaryな技術を用いたHigh Content Screening (HCS)、Phenotypic Screening等の様々なアプローチにより、CNS研究、癌研究を中心にサポートします。 Disease Models (Cell Lines). Disease Models (Primary Cells). Phenotypic Screening platform High Content Analysis. Fluorescent GPCR Internalization Assay. Activation and Internalization assay for CCR2-tGFP (Ec50 =0.73 ng/ml). Internalization of CCR2 stimulated with human MCP-1. Concentrations from 0 to 10 μg/ml were tested for 3h. Redistr...
sictec-project.eu
Single Cell Technologies for SMEs: PASCA
http://www.sictec-project.eu/pasca
Single Cell Technologies for SMEs. 32;» PASCA. PASCA - Platform for Advanced Single Cell Manipulation and Analysis. The European research project PASCA (Platform for Advanced Single Cell Manipulation and Analysis) was the preceding project for SICTEC. Sophion Bioscience A/S (Denmark), University of Dublin, Trinity College (Ireland), Primadiag SAS (France), BioFluidix GmbH (Germany), Zurich Instruments AG (Switzerland) and INNOPROT (Spain). University of Freiburg, IMTEK (Germany). Contact: Jonatan Kutchi...
fibrotargets.eu
Teams
http://www.fibrotargets.eu/about-us/teams-institutions/teams
INSTITUT MEDICAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM). CIC and U 1116. Professor of Therapeutics and Cardiology, Head of CIC. CIC-P INSERM / CHU. Tel : 33 3 83 15 73 22. This email address is being protected from spambots. You need JavaScript enabled to view it. Faiez Zannad is Professor of Therapeutics and Cardiology. MD, PhD, Director of INSERM Unit U1138. 15, rue de l'Ecole de Medecine. 75270 Paris Cedex 06. 1 44 27 81 06. Dr JAISSER received his medical training and degrees from the Reims...
fibrotargets.eu
Partner institutions
http://www.fibrotargets.eu/about-us/teams-institutions/partner-institutions
Institut National de la Santé Et de la Recherche Médicale (INSERM). INSERM is a public institution with a scientific and technical vocation, under the dual auspices of the French Ministry of Health and the Ministry of Higher Education and Research. Its researchers are committed to studying all human diseases, whether common or rare, through their research in the fields of biology, medicine, and public health. Inserm Transfert SA (IT). Fundacion para la Investigacion Medica Aplicada (FIMA). Greenpharma is...
r2r-biofluidics.eu
Project partners
http://www.r2r-biofluidics.eu/project/project-partners
JOANNEUM RESEARCH Forschungsgesellschaft mbH (JR). BiFlow Systems GmbH (BIF). BioNanoNet Forschungsgesellschaft mbH (BNN). Bionic surface technologies GmbH (BST). GENSPEED Biotech GmbH (GSB). Inmold Biosystems A/S (IM). Innovative Technologies in Biological Systems S.L. (IPT). Fundación Tecnalia Research and Innovation (TRI). R2R Biofluidics – Coordinated by JOANNEUM RESEARCH – MATERIALS. Institute for Surface Technologies and Photonics.
seedcapitalbizkaia.com
Fund I | Seed Capital Bizkaia
http://www.seedcapitalbizkaia.com/en/herramientas-de-financiacion/fondo-i
Jump to the content. What is Seed Capital de Bizkaia? Can we help you? What is Seed Capital? How do we invest. Can we help you? 8220;Seed Capital de Bizkaia”, F.C.R. de Régimen Común. This is a venture capital Fund set up in 1990. The promotion of innovative business initiatives. New or recently created companies. With registered address and a production centre in Bizkaia. Share capital of at least 90,000. With growth and job creation potential. Up to 450,000 in capital and loan. Fixed : Euribor 2.5.
manahmana.blogspot.com
manahmana: junio 2009
http://manahmana.blogspot.com/2009_06_01_archive.html
Ir a la barra lateral. Foro para la igualdad 2009. 26 jun. 2009. He aquí mi primer acercamiento a un foro de EMAKUNDE y para ser más concretos el VI.Berdintasunerako gunea – foro para la igualdad 2009 que transcurrió del 4 al 21 de Junio. Que por cierto, desde manahmana quiero felicitarle por la sencillez y lo agradable que presentó los temas tan delicados) en cada mesa se mantuvieron charlas, debates y varias aportaciones a cada tema. Mesa 1: Mujer, empresa y urbanismo. Mesa 2: Mujer, empresa y liderazgo.